Egg Freezing and Embryo Banking Market Size & Growth Forecast 2027–2036, By Segments (Type, Preservation, Age of Patient), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Egg Freezing and Embryo Banking Market size was estimated at USD 7.4 billion in 2026 and is projected to grow at a 15.96% CAGR from 2027 to 2036, surpassing USD 32.53 billion by 2036. The industry revenue for 2027 is calculated at USD 8.39 billion.
Get more details on this report
Request Free Sample ReportEgg Freezing and Embryo Banking Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through established fertility infrastructure, specialized clinics, advanced laboratory capabilities, and strong awareness of elective and medically indicated fertility preservation services.
- Asia Pacific is projected to expand at an 18.82% CAGR, fueled by wider fertility treatment access, growing IVF infrastructure, rising fertility planning awareness, and increasing demand through private clinics.
Segment Momentum
- Embryo freezing held a 68.93% share in 2026 because it is well integrated into IVF workflows, supporting treatment planning, cycle management, and future embryo transfer.
- Egg freezing is the fastest-growing preservation segment due to rising demand for fertility preservation flexibility before fertilization decisions are made, helping individuals retain future reproductive options.
Market Expansion Drivers
- Delayed parenthood trends increasing adoption of fertility preservation services globally.
- Rising infertility prevalence driving demand for assisted reproductive technology procedures.
- Government-backed fertility treatment rebates improving accessibility to egg freezing procedures.
Leading Market Participants
- Top players in the egg freezing and embryo banking market include Cryoport, Inc. (United States), ReproTech LLC (United States), Cryos International ApS (Denmark), CCRM Management Company, LLC (United States), RMA Network (United States), WINFertility, Inc. (United States), Kindbody, Inc. (United States), Shady Grove Fertility (United States), CooperSurgical, Inc. (United States), IVIRMA Global (Spain).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.4 billion
- 2027 Estimated Market Size: USD 8.39 billion.
- Projected Market Size: USD 32.53 billion by 2036
- Growth Forecast: 15.96% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Nondonor (Type) | Embryo Freezing (Preservation) | Under 35 (Age of Patient)
- Emerging Opportunity Segment: Donor (Type) | Egg Freezing (Preservation) | 35-37 (Age of Patient)
Market Growth Drivers and Industry Trends
Delayed parenthood trends increasing adoption of fertility preservation services globally
Later family formation is encouraging individuals to consider fertility preservation before age-related changes in reproductive potential become more significant, supporting the egg freezing and embryo banking market. Women postponing childbearing for personal, educational, or career-related reasons may increasingly view egg or embryo preservation as a means of maintaining future reproductive options. Greater awareness of available preservation procedures and improved acceptance of fertility planning are also encouraging individuals to seek reproductive services earlier, contributing to demand for ovarian stimulation, retrieval, cryopreservation, and storage services.
Rising infertility prevalence driving demand for assisted reproductive technology procedures
Increasing infertility challenges are strengthening reliance on assisted reproductive technologies, which will boost the egg freezing and embryo banking market as fertility clinics incorporate preservation into broader treatment pathways. Patients undergoing fertility treatment may preserve eggs or embryos for subsequent treatment cycles, while embryo banking can provide additional flexibility when multiple embryos are created during assisted reproduction. The growing need for personalized fertility treatment and the ability to store reproductive material for later use support continued utilization of cryopreservation and related laboratory services.
Government-backed fertility treatment rebates improving accessibility to egg freezing procedures
Publicly supported fertility treatment rebates can reduce financial barriers associated with preservation procedures, allowing a broader range of eligible individuals to consider fertility services and supporting the egg freezing and embryo banking market. When governments provide financial assistance for qualifying reproductive treatments, the affordability of procedures such as ovarian stimulation, egg retrieval, and cryopreservation can improve. Increased financial accessibility can also encourage patients who may otherwise postpone fertility preservation because of treatment costs to engage with fertility clinics and evaluate preservation options.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Delayed parenthood trends increasing adoption of fertility preservation services globally | 2.40% | Moderate | Europe, North America, Asia Pacific | High | Near Term |
| Rising infertility prevalence driving demand for assisted reproductive technology procedures | 2.10% | High | Europe, Asia Pacific, North America | High | Near Term |
| Government-backed fertility treatment rebates improving accessibility to egg freezing procedures | 1.60% | High | Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The egg freezing and embryo banking market was led by North America in 2026, supported by advanced fertility-care infrastructure, widespread availability of assisted reproductive technologies, and growing awareness of fertility preservation. Greater acceptance of delayed family planning and increasing interest in preserving reproductive options are strengthening demand. Improvements in cryopreservation techniques, specialized fertility services, and access to comprehensive reproductive care are also supporting the region's established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region, driven by improving fertility-care infrastructure, rising awareness of reproductive preservation, and broader access to assisted reproductive services. Changing family-planning preferences, delayed parenthood, and increasing interest in fertility options are encouraging demand among individuals seeking greater flexibility in reproductive decisions. Expanding healthcare capabilities and improving availability of specialized fertility centers are further supporting market development across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Regulated Clinical ExpansionGermany prioritizes fertility preservation within a tightly regulated reproductive healthcare framework, encouraging clinics to optimize laboratory quality and patient outcomes. Demand is increasingly supported by medical preservation needs and greater public awareness of reproductive health options.
France 🇫🇷
Public-Private Fertility AccessFrance is expanding access to fertility preservation through evolving healthcare policies and established reproductive medicine networks. Egg freezing and embryo banking services increasingly benefit from coordinated clinical standards and broader patient eligibility across specialized treatment centers.
Italy 🇮🇹
Specialized Reproductive ServicesItaly continues strengthening fertility preservation capabilities through specialized reproductive clinics focused on improved cryopreservation protocols. Growing patient interest in reproductive planning and medical fertility preservation supports wider adoption of egg freezing and embryo banking services.
Japan 🇯🇵
Delayed Parenthood SupportJapan is strengthening fertility preservation services as later family planning increases interest in egg freezing and embryo banking. Healthcare providers continue expanding counseling, cryostorage capacity, and specialized reproductive care to address changing demographic and lifestyle trends.
South Korea 🇰🇷
Technology-Driven Fertility CareSouth Korea integrates advanced assisted reproductive technologies with modern fertility preservation services, encouraging wider adoption among individuals delaying parenthood. Clinics continue investing in laboratory capabilities and personalized reproductive treatment pathways to enhance patient confidence.
United States 🇺🇸
Fertility Innovation HubThe U.S. market emphasizes expanded fertility preservation services through specialized reproductive clinics and advanced cryopreservation technologies. Growing employer-supported fertility benefits and increasing awareness of reproductive planning continue to strengthen demand for egg freezing and embryo banking across the country.
Segment Leadership and Growth Trends
Egg Freezing and Embryo Banking Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Nondonor (Largest Segment) vs Donor (Fastest-Growing Segment)
Holding the largest share of 55.65% in 2026, the nondonor segment benefits from increasing demand among individuals and couples seeking to preserve their own reproductive material for future family-building plans. Greater awareness of fertility preservation, delayed parenthood, and reproductive planning is encouraging more people to consider cryopreservation as part of long-term family planning. Improvements in assisted reproductive technologies and greater acceptance of fertility preservation are also strengthening demand for services involving patients' own eggs and embryos.
The donor segment is gaining traction as assisted reproduction increasingly provides options for individuals and couples who cannot achieve pregnancy using their own reproductive material. Greater awareness of donor-assisted fertility treatments, expanding access to reproductive services, and improvements in screening and preservation practices are supporting adoption. Increasing social acceptance of assisted reproduction and the availability of more individualized treatment pathways are further contributing to the segment's growth.
Preservation Segment Analysis: Embryo Freezing (Largest Segment) vs Egg Freezing (Fastest-Growing Segment)
The embryo freezing segment represented the largest share of 68.93% in 2026, reflecting its established role in assisted reproductive treatment and fertility preservation. Embryo cryopreservation enables reproductive specialists to preserve embryos for subsequent transfer, supporting treatment planning and providing flexibility across fertility cycles. Continued improvements in cryopreservation techniques and growing utilization of assisted reproductive procedures are reinforcing the importance of embryo banking within fertility care.
Egg freezing is advancing rapidly as fertility preservation becomes increasingly relevant to individuals seeking greater flexibility over the timing of parenthood. Improvements in oocyte cryopreservation have strengthened the viability of stored eggs for future reproductive use, while increasing awareness of age-related fertility considerations is encouraging earlier preservation decisions. Broader acceptance of elective fertility preservation and expanding reproductive healthcare access are further supporting demand for egg banking services.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Donor, Nondonor | Nondonor | Donor |
| Preservation | Egg Freezing, Embryo Freezing | Embryo Freezing | Egg Freezing |
| Age of Patient | Under 35, 35-37, 38-40, Over 42 | Under 35 | 35-37 |
Competitive Landscape and Market Positioning
Major players in the egg freezing and embryo banking market:
1. Cryoport Inc. (United States)
2. ReproTech LLC (United States)
3. Cryos International ApS (Denmark)
4. CCRM Management Company LLC (United States)
5. RMA Network (United States)
6. WINFertility Inc. (United States)
7. Kindbody Inc. (United States)
8. Shady Grove Fertility (United States)
9. CooperSurgical Inc. (United States)
10. IVIRMA Global (Spain)
The egg freezing and embryo banking market is experiencing increased investment in advanced cryopreservation technologies and automated laboratory systems designed to improve storage efficiency and reproductive outcomes. Service providers are expanding fertility preservation programs and personalized patient support services to strengthen market presence. Rising awareness regarding reproductive planning and delayed parenthood trends continues to support growth across the egg freezing and embryo banking market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Cryoport Inc. (United States) | |||||||
| ReproTech LLC (United States) | |||||||
| Cryos International ApS (Denmark) | |||||||
| CCRM Management Company LLC (United States) | |||||||
| RMA Network (United States) | |||||||
| WINFertility Inc. (United States) | |||||||
| Kindbody Inc. (United States) | |||||||
| Shady Grove Fertility (United States) | |||||||
| CooperSurgical Inc. (United States) | |||||||
| IVIRMA Global (Spain). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| KKR | Mar-25 | KKR completed a private equity acquisition of fertility clinic operator Eugin Group in a transaction valued at EUR 525 million. The deal adds 69 specialized IVF and cryopreservation clinics across 11 countries to KKR's global healthcare portfolio, significantly expanding its market share in reproductive health services. |
| TMRW Life Sciences | Mar-25 | TMRW Life Sciences launched the TMRW Vault, an automated liquid-nitrogen cryostorage tank for frozen eggs and embryos. The system introduces RFID chip tagging on individual specimen straws to enable automated tracking and real-time medical record integration, significantly enhancing biometric specimen safety and digital inventory management. |
| Spermosens AB | Mar-24 | Spermosens AB secured SEK 10.8 million in financing to accelerate the clinical validation of its JUNO-Checked diagnostic test. Designed to detect specific sperm-egg binding functional failures in laboratory settings, the funding supports the company's objective to license the technology to clinical IVF centers. |
| IVIRMA Global | Nov-23 | IVIRMA Global, in partnership with GED Capital, acquired the fertility and cryobank operations of Barcelona-based Eugin Group for up to EUR 500 million, including earn-outs. The strategic cross-border transaction expands IVIRMA's operational infrastructure and market reach across European and North American fertility networks. |
| Pinnacle Fertility | Jun-23 | Pinnacle Fertility partnered with TMRW Life Sciences to integrate TMRW's automated digital specimen management platform across its clinic network. This technology integration transitions the provider's egg and embryo cryo-storage infrastructure from manual tracking to automated, digitally monitored workflows to increase operational accuracy. |
| Boston IVF | Jun-21 | Boston IVF partnered with TMRW Life Sciences to deploy automated cryostorage and reproductive cell management technology across its 25 clinical locations. The strategic collaboration automates the clinic group's bio-banking inventory, reducing manual handling risks and improving processing safety for frozen patient specimens. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Egg Freezing and Embryo Banking Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Fertility Clinic Type | Hospital-Based Fertility Centers, Independent Fertility Clinics, Academic & Research Fertility Centers |
| Funding Source | Self-Pay, Private Insurance, Public Funding & Government Programs |
| Storage Duration | Short-Term Storage, Medium-Term Storage, Long-Term Storage |
Egg Freezing and Embryo Banking Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Patient Decision-Making and Treatment Journey Analysis |
|
| Employer Fertility Benefits Adoption Analysis |
|
| Fertility Tourism Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much is the egg freezing and embryo banking market worth?
How is the egg freezing and embryo banking industry expected to grow over the next 10 years?
How are delayed parenthood trends influencing demand for fertility preservation services?
Why are government-backed fertility treatment rebates important for market growth?
Why is embryo freezing the largest preservation segment in the egg freezing and embryo banking market?
What is driving the rapid growth of egg freezing services?
What makes North America the largest market for egg freezing and embryo banking?
Why is Asia Pacific the fastest-growing egg freezing and embryo banking market?
What are the key competitors in the egg freezing and embryo banking landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization